Crown Electrokinetics Corp. Transition report pursuant to Rule 13a-10 or 15d-10

Transition report pursuant to Rule 13a-10 or 15d-10

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - USD ($)										1 Months Ended		9 Months Ended	12 Months Ended
Stockholders' Deficit (Details) - USD ($)	Apr. 27, 2021	Feb. 19, 2021	Feb. 16, 2021	Jan. 28, 2021	Jan. 26, 2021	Jan. 22, 2021	Jan. 05, 2021	Sep. 11, 2020	Jun. 06, 2020	Mar. 31, 2021	Jan. 26, 2021	Dec. 31, 2021	Mar. 31, 2021	Jun. 30, 2020
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized										50,000,000		50,000,000	50,000,000
Preferred stock, par value (in Dollars per share)										$ 0.0001		$ 0.0001	$ 0.0001
Underwriters’ discount (in Dollars per share)					$ 4.5
Proceeds from public offering (in Dollars)				$ 19,300,000
Proceeds from underwriter fee and commission (in Dollars)				1,700,000
Proceeds from offering cost (in Dollars)				$ 400,000
Purchase of underwriters (in Dollars)											$ 381,800	$ 381,800,000
Warrants exercise price (in Dollars per share)												$ 5.625
Shares issued														97,222
Warrant liability (in Dollars)								$ 600,000
Fair value warrants (in Dollars)										$ 1,100,000		$ 200,000	$ 1,100,000
Restricted common stock shares Issued										366,667
Shares issued												64,261
Convertible notes (in Dollars)										$ 17,100,000			17,100,000
Conversion feature of note exchange agreement (in Dollars)													6,600,000
Value of warrants (in Dollars)													263,000
Convertible Notes [Member]
Stockholders' Deficit (Details) [Line Items]
Fair value warrants (in Dollars)										$ 10,600,000			$ 10,600,000
Restricted common stock shares Issued													2,830,079
Series A Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized							300			300		300	300
Preferred stock, par value (in Dollars per share)							$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock stated valued per share (in Dollars per share)							$ 1,000
Annual rate, percentage							8.00%
Conversion price (in Dollars per share)							$ 1,332.9000
Shares issued													251
Number of convertible shares										188,311		251	188,311
Fair value warrants (in Dollars)										$ 1,300,000			$ 1,300,000
Restricted common stock shares Issued													251
Series B Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized						1,500				1,500		1,500	1,500
Preferred stock, par value (in Dollars per share)						$ 0.0001				$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock stated valued per share (in Dollars per share)						$ 1,000
Annual rate, percentage						8.00%
Conversion price (in Dollars per share)						$ 0.7149
Shares issued												1,443
Number of convertible shares										2,019,038		1,443	2,019,038
Fair value warrants (in Dollars)										$ 9,400,000			$ 9,400,000
Restricted common stock shares Issued													1,443
Series C Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized		600,000								600,000		600,000	600,000
Preferred stock, par value (in Dollars per share)		$ 0.0001								$ 0.0001		$ 0.0001	$ 0.0001
Annual rate, percentage		8.00%
Conversion price (in Dollars per share)		$ 0.893
Shares issued													500,756
Number of convertible shares										560,757		500,756	560,757
Preferred stock, par value (in Dollars per share)		$ 1
Fair value warrants (in Dollars)										$ 2,400,000			$ 2,400,000
Restricted common stock shares Issued													500,756
Equity Option [Member]
Stockholders' Deficit (Details) [Line Items]
Stock option description												During the nine months ended December 31, 2021, the Company issued 409,385 shares of its common stock in connection with the exercise of stock options and received proceeds of approximately $0.2 million.	During the fiscal year ended March 31, 2021, the Company issued 25,000 shares of its common stock in connection with the exercise of stock options, with an exercise price of $0.15 per share. During April 2021, the Company received proceeds of $3,750.
Common Stock [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)					0.0001						$ 0.0001
Fair value warrants (in Dollars)										$ 300,000			$ 300,000
Restricted common stock shares Issued	54,149
Shares issued										108,792
Accounts payable (in Dollars)	$ 100,000
Warrants exercise													316,421
Value of warrants (in Dollars)
Common Stock [Member] \| Restricted Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Common stock shares issued										3			3
Purchase restricted stock										166,667			166,667
Fair value warrants (in Dollars)										$ 500,000			$ 500,000
Restricted common stock shares Issued										800,000
Common Stock [Member] \| Financing [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)								$ 0.0001
Share price (in Dollars per share)								1.25
Warrants exercise price (in Dollars per share)								$ 1.5
Sale of aggregate shares								463,333
Purchase of warrants								231,667
Proceeds from private placement (in Dollars)								$ 1,700,000
Warrant description								The Company is not required to issue common stock upon exercise of any portion of a warrant if doing so results in the warrant holder beneficially owning more than 4.99% of the outstanding common stock after giving effect to such exercise.
Transaction fees (in Dollars)								$ 139,000
Shares issued								36,033
Common Stock [Member] \| Chief Executive Officer [Member]
Stockholders' Deficit (Details) [Line Items]
Vested restricted common stock										1,571,428			1,571,428
Common Stock [Member] \| Public Offering [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)					$ 0.0001						0.0001
Underwriters shares					4,772,500
Share price (in Dollars per share)					$ 4.14						$ 4.14
Warrant [Member]
Stockholders' Deficit (Details) [Line Items]
Warrants exercise price (in Dollars per share)												$ 5,625
Purchase of warrants												381,800
Warrant liability (in Dollars)													$ 2,360,543
Fair value warrants (in Dollars)									$ 100,000
Restricted common stock shares Issued			53,093
warrants purchased									116,667				208,000
Warrants exercise			53,093										53,093
Value of warrants (in Dollars)			$ 200,000
Warrants description										During the fiscal year ended March 31, 2021, the Company issued 166,106 shares of its common stock in connection with the exercise of 166,667 common stock warrants on a cashless basis.